IN2012CH03125A - - Google Patents

Download PDF

Info

Publication number
IN2012CH03125A
IN2012CH03125A IN3125CH2012A IN2012CH03125A IN 2012CH03125 A IN2012CH03125 A IN 2012CH03125A IN 3125CH2012 A IN3125CH2012 A IN 3125CH2012A IN 2012CH03125 A IN2012CH03125 A IN 2012CH03125A
Authority
IN
India
Prior art keywords
febuxostat
pharmaceutical composition
pharmaceutically acceptable
acceptable salt
bioavailability
Prior art date
Application number
Other languages
English (en)
Inventor
Allada Ramesh
Chandra Illapakurthy Dr Ashok
S Rudraraju Dr Varma
Patra Srikanta
Original Assignee
Aizant Drug Res Solutions Private Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aizant Drug Res Solutions Private Ltd filed Critical Aizant Drug Res Solutions Private Ltd
Priority to IN3125CH2012 priority Critical patent/IN2012CH03125A/en
Publication of IN2012CH03125A publication Critical patent/IN2012CH03125A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IN3125CH2012 2012-07-31 2012-07-31 IN2012CH03125A (cs)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN3125CH2012 IN2012CH03125A (cs) 2012-07-31 2012-07-31

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3125CH2012 IN2012CH03125A (cs) 2012-07-31 2012-07-31

Publications (1)

Publication Number Publication Date
IN2012CH03125A true IN2012CH03125A (cs) 2015-07-03

Family

ID=54397191

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3125CH2012 IN2012CH03125A (cs) 2012-07-31 2012-07-31

Country Status (1)

Country Link
IN (1) IN2012CH03125A (cs)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021099935A1 (en) * 2019-11-18 2021-05-27 Zycie Technolegal Llp Pharmaceutical formulations for managing uric acid content in human body

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021099935A1 (en) * 2019-11-18 2021-05-27 Zycie Technolegal Llp Pharmaceutical formulations for managing uric acid content in human body

Similar Documents

Publication Publication Date Title
IN2014KN00948A (cs)
NZ704662A (en) Crystalline forms of the prolyl hydroxylase inhibitor [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid
EA201690287A1 (ru) 1,4-дизамещенные аналоги пиридазин хинолина и способы лечения состояний, связанных с smn-дефицитом
SG10201804817TA (en) Delayed release compositions of linaclotide
PT2542535E (pt) Formas cristalinas para sal de sódio de 5-amino-2,3-di hidroftalazino-1,4-diona, preparações farmacêuticas contendo o mesmo e processo para a produção das ditas formas
PH12014501542B1 (en) Substituted pyrrolidine -2- carboxamides
WO2014045162A8 (en) ALKYL-SUBSTITUTED HEXAHYDROPYRANO[3,4-d] [1,3]THIAZIN-2-AMINE COMPOUNDS
ZA201301463B (en) Pharmaceutical compositions for calonolides,their derivatives and analogues,and process for producing the same
WO2011009938A3 (en) Stambomycin and derivatives, their production and their use as drugs
UA115357C2 (uk) Похідні піридин-4-ілу
MX2012001691A (es) Composiciones de linaclotida que se desintegran oralmente.
UA112764C2 (uk) Оптимізований синтез чистих, неполіморфних кристалічних жовчних кислот із заданим розміром частинок
MX2011011767A (es) Combinacion antitumoral que comprende ave8062 y sorafenib.
PH12015500395A1 (en) Pharmaceutical composite capsule formulation comprising irbesartan and hmg-coa reductase inhibitor
WO2012019428A8 (zh) 二苯甲醇类衍生物、其制备方法及其在医药上的应用
MD20140122A2 (ro) Procedee de producere a clorhidratului de anamorelin cu un conţinut controlat de clorură
MX367773B (es) Forma salina sólida de la alfa-6-mpeg6-o-hidroxicodona como agonistas opioides y sus usos.
EA201190282A1 (ru) Фармацевтическая композиция, содержащая тамсулозин
IN2012CH03125A (cs)
IL236562A0 (en) A pharmaceutical preparation with an improved flow capacity, a medical agent, and a method for its production and use
MX342465B (es) Metodos para tratar enfermedades hematologicas usando 6-ciclohexil-1-hidroxi-4-metil-2(1h)-piridona.
WO2013083226A8 (de) Porenarmes, wasserfreies natriumcarbonat
IN2015DN01463A (cs)
IN2014DN07897A (cs)
MX346497B (es) Compuestos para la diferenciacion de celulas madre mejorada en hepatocitos.